Your browser doesn't support javascript.
loading
Physical activity in idiopathic pulmonary fibrosis: Longitudinal change and minimal clinically important difference.
Shingai, Kazuya; Matsuda, Toshiaki; Kondoh, Yasuhiro; Kimura, Tomoki; Kataoka, Kensuke; Yokoyama, Toshiki; Yamano, Yasuhiko; Ogawa, Tomoya; Watanabe, Fumiko; Hirasawa, Jun; Reid, W Darlene; Kozu, Ryo.
Afiliação
  • Shingai K; Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
  • Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
  • Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
  • Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
  • Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
  • Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
  • Ogawa T; Department of Rehabilitation, Tosei General Hospital, Seto, Japan.
  • Watanabe F; Department of Rehabilitation, Tosei General Hospital, Seto, Japan.
  • Hirasawa J; Department of Rehabilitation, Tosei General Hospital, Seto, Japan.
  • Reid WD; Department of Physical Therapy, University of Toronto, Toronto, Canada.
  • Kozu R; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Chron Respir Dis ; 20: 14799731231221818, 2023.
Article em En | MEDLINE | ID: mdl-38108832
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Reference values of physical activity to interpret longitudinal changes are not available in patients with idiopathic pulmonary fibrosis (IPF). This study aimed to define the minimal clinical important difference (MCID) of longitudinal changes in physical activity in patients with IPF.

METHODS:

Using accelerometry, physical activity (steps per day) was measured and compared at baseline and 6-months follow-up in patients with IPF. We calculated MCID of daily step count using multiple anchor-based and distribution-based methods. Forced vital capacity and 6-minute walk distance were applied as anchors in anchor-based methods. Effect size and standard error of measurement were used to calculate MCID in distribution-based methods.

RESULTS:

One-hundred and five patients were enrolled in the study (mean age 68.5 ± 7.5 years). Step count significantly decreased from baseline to 6-months follow-up (-461 ± 2402, p = .031). MCID calculated by anchor-based and distribution-based methods ranged from 570-1358 steps.

CONCLUSION:

Daily step count significantly declined over 6-months in patients with IPF. MCID calculated by multiple anchor-based and distribution-based methods was 570 to 1358 steps/day. These findings contribute to interpretation of the longitudinal changes of physical activity that will assist its use as a clinical and research outcome in patients with IPF.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Diferença Mínima Clinicamente Importante Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Diferença Mínima Clinicamente Importante Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article